Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Adare Pharma Solutions Expands Philadelphia, Pennsylvania, Operations

08/05/2024
Adare Pharma Solutions, a contract development and manufacturing organization, plans to expand its operations in Philadelphia, Pennsylvania. The $16.8 million project is expected to create 115 jobs.

The investment will include the expansion of the company’s two manufacturing and packaging facilities and the relocation of its headquarters to the Dungan Road location.

“We are thrilled to announce the relocation of Adare’s global headquarters to Philadelphia,” said Tom Sellig, CEO, Adare Pharma Solutions. “This decision showcases the efforts of both Pennsylvania and Philadelphia in becoming an important life sciences hub for companies like Adare. It is crucial for us to have access to a highly skilled talent pool and key markets, and the Philadelphia area provides exactly what we need.”

Adare received a funding proposal from the Pennsylvania Department of Community and Economic Development for a $2.4 million Pennsylvania Industrial Development Authority loan, a $460,000 Pennsylvania First grant, and a $100,000 workforce development grant to train workers.

“Life Sciences is one of the five key sectors in our Economic Development Strategy, and we’re committed to making sure the industry continues to grow and thrive in the Commonwealth,” noted DCED Secretary Rick Siger. “Today’s announcement is a great example of this growth, and we’re thrilled to support Adare as yet another industry leader establishes their headquarters in Pennsylvania.”

Adare Pharma Solutions provides end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise focusing on oral dosage forms for the pharmaceutical industry. The company currently operations seven facilities in the U.S. and Europe.

Exclusive Research